1. Home
  2. IRIX vs NEPH Comparison

IRIX vs NEPH Comparison

Compare IRIX & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IRIX
  • NEPH
  • Stock Information
  • Founded
  • IRIX 1989
  • NEPH 1997
  • Country
  • IRIX United States
  • NEPH United States
  • Employees
  • IRIX N/A
  • NEPH N/A
  • Industry
  • IRIX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • NEPH Medical/Dental Instruments
  • Sector
  • IRIX Health Care
  • NEPH Health Care
  • Exchange
  • IRIX Nasdaq
  • NEPH Nasdaq
  • Market Cap
  • IRIX 20.6M
  • NEPH 16.8M
  • IPO Year
  • IRIX 1996
  • NEPH 2004
  • Fundamental
  • Price
  • IRIX $1.03
  • NEPH $2.03
  • Analyst Decision
  • IRIX Hold
  • NEPH Buy
  • Analyst Count
  • IRIX 1
  • NEPH 1
  • Target Price
  • IRIX $2.00
  • NEPH $5.00
  • AVG Volume (30 Days)
  • IRIX 142.5K
  • NEPH 12.2K
  • Earning Date
  • IRIX 03-27-2025
  • NEPH 05-08-2025
  • Dividend Yield
  • IRIX N/A
  • NEPH N/A
  • EPS Growth
  • IRIX N/A
  • NEPH N/A
  • EPS
  • IRIX N/A
  • NEPH 0.01
  • Revenue
  • IRIX $48,669,000.00
  • NEPH $14,162,000.00
  • Revenue This Year
  • IRIX N/A
  • NEPH $9.23
  • Revenue Next Year
  • IRIX $5.44
  • NEPH $12.99
  • P/E Ratio
  • IRIX N/A
  • NEPH $290.01
  • Revenue Growth
  • IRIX N/A
  • NEPH N/A
  • 52 Week Low
  • IRIX $0.78
  • NEPH $1.36
  • 52 Week High
  • IRIX $3.65
  • NEPH $2.55
  • Technical
  • Relative Strength Index (RSI)
  • IRIX 45.12
  • NEPH 76.08
  • Support Level
  • IRIX $0.78
  • NEPH $1.55
  • Resistance Level
  • IRIX $1.07
  • NEPH $1.62
  • Average True Range (ATR)
  • IRIX 0.12
  • NEPH 0.10
  • MACD
  • IRIX 0.02
  • NEPH 0.04
  • Stochastic Oscillator
  • IRIX 54.35
  • NEPH 98.18

About IRIX IRIDEX Corporation

IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease.

Share on Social Networks: